1. Delnooz CC, Lefeber DJ, Langemeijer SM, Hoffjan S, Dekomien G, Zwarts MJ, et al. New cases of adult-onset Sandhoff disease with a cerebellar or lower motor neuron phenotype. J Neurol Neurosurg Psychiatry. 2010; 81:968–972. PMID:
20798201.
Article
2. Saouab R, Mahi M, Abilkacem R, Boumdin H, Chaouir S, Agader O, et al. A case report of Sandhoff disease. Clin Neuroradiol. 2011; 21:83–85. PMID:
21153386.
Article
3. Hall P, Minnich S, Teigen C, Raymond K. Diagnosing Lysosomal Storage Disorders: The GM2 Gangliosidoses. Curr Protoc Hum Genet. 2014; 83:17.16.1–17.16.8. PMID:
25271840.
Article
4. Weckmueller J, Easterling C, Arvedson J. Preliminary temporal measurement analysis of normal oropharyngeal swallowing in infants and young children. Dysphagia. 2011; 26:135–143. PMID:
20532920.
Article
5. World Health Organization Multicentre Growth Reference Study Group. WHO Child Growth Standards: length/height for age, weight for age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization;2006.
6. Morgan AT, Dodrill P, Ward EC. Interventions for oropharyngeal dysphagia in children with neurological impairment. Cochrane Database Syst Rev. 2012; 10:CD009456. PMID:
23076958.
Article
7. Smith NJ, Winstone AM, Stellitano L, Cox TM, Verity CM. GM2 gangliosidosis in a UK study of children with progressive neurodegeneration: 73 cases reviewed. Dev Med Child Neurol. 2012; 54:176–182. PMID:
22115551.
Article
8. Bley AE, Giannikopoulos OA, Hayden D, Kubilus K, Tifft CJ, Eichler FS. Natural history of infantile G(M2) gangliosidosis. Pediatrics. 2011; 128:e1233–e1241. PMID:
22025593.
Article
9. Jeyakumar M, Norflus F, Tifft CJ, Cortina-Borja M, Butters TD, Proia RL, et al. Enhanced survival in Sandhoff disease mice receiving a combination of substrate deprivation therapy and bone marrow transplantation. Blood. 2001; 97:327–329. PMID:
11133779.
Article